Four-Drug Combo for HCV Shows Early Promise

posted on Jul 26 by MedPage Today OB/Gyn in the Uncategorized category (MedPage Today) -- Combining traditional therapy for HCV infection with the newly approved drug telaprevir (Incivek) and an investigational oral HCV polymerase inhibitor boosted 24-week complete virologic response rates to 90% in a phase II study, the drugs' manufacturer said.